Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: But it does not have a prognostic significance

Genetics and Molecular Research

Volumn 6, Issue 1, 2007, Pages 41-49

  Gumux Akay G ^a   Unal A E ^a   Bayar, S ^a   Karadayi, K ^a   Elhan, A H ^a   Sunguroglu A ^a   Tukun A ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Gastric adenocarcinoma; Telomerase activity; Tumor progression

Indexed keywords

TELOMERASE; TUMOR MARKER;

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALIGNANT TRANSFORMATION; PROGNOSIS; STOMACH ADENOCARCINOMA; STOMACH MUCOSA;

ADENOCARCINOMA; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STOMACH NEOPLASMS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 34248382110     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ahn MJ, Noh YH, Lee YS, Lee JH, et al. (1997). Telomerase activity and its clinicopathological significance in gastric cancer. Eur. J. Cancer 33: 1309-1313.
2. Chan SR and Blackburn EH (2004). Telomeres and telomerase. Philos. Trans. R. Soc. Lond. B Biol. Sci. 359: 109-121.
3. Dong CK, Masutomi K and Hahn WC (2005). Telomerase: regulation, function and transformation. Crit. Rev. Oncol. Hematol. 54: 85-93.
4. Furugori E, Hirayama R, Nakamura KI, Kammori M, et al. (2000). Telomere shortening in gastric carcinoma with aging despite telomerase activation. J. Cancer Res. Clin. Oncol. 126: 481-485.
5. Granger MP, Wright WE and Shay JW (2002). Telomerase in cancer and aging. Crit. Rev. Oncol. Hematol. 41: 29-40.
6. Hahn WC (2005). Telomere and telomerase dynamics in human cells. Curr. Mol. Med. 5: 227-231.
7. Heine B, Hummel M, Demel G and Stein H (1998). Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization. J. Pathol. 185: 139-144.
8. Ishigami S, Natsugoe S, Tokuda K, Nakajo A, et al. (2000a). Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer. Cancer Lett. 159: 103-108.
9. Ishigami S, Natsugoe S, Tokuda K, Nakajo A, et al. (2000b). Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer 88: 577-583.
10. Jong HS, Park YI, Kim S, Sohn JH, et al. (1999). Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer 86: 559-565.
11. Kameshima H, Yagihashi A, Yajima T, Kobayashi D, et al. (2000). Helicobacter pylori infection: augmentation of telomerase activity in cancer and noncancerous tissues. World J. Surg. 24: 1243-1249.
12. Kim JH, Lee GE, Kim JC, Lee JH, et al. (2002). A novel telomere elongation in an adriamycin-resistant stomach cancer cell line with decreased telomerase activity. Mol. Cells 13: 228-236.
13. Klingelhutz AJ (1997). Telomerase activation and cancer. J. Mol. Med. 75: 45-49.
14. Muntoni A and Reddel RR (2005). The first molecular details of ALT in human tumor cells. Hum. Mol. Genet. 14 (Spec No. 2): R191-R196.
15. Nakamura Y, Tahara E, Tahara H, Yasui W, et al. (1999). Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues. Mol. Carcinog. 26: 312-320.
16. Nowak J, Januszkiewicz D, Lewandowski K, Nowicka-Kujawska K, et al. (2003). Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients. Eur. J. Gastroenterol. Hepatol. 15: 75-80.
17. Okusa Y, Ichikura T, Mochizuki H and Shinomiya N (2000). Clinical significance of telomerase activity in biopsy specimens of gastric cancer. J. Clin. Gastroenterol. 30: 61-63.
18. Opitz OG (2005). Telomeres, telomerase and malignant transformation. Curr. Mol. Med. 5: 219-226.
19. Rathi A, Hur K, Gazdar AF, Bae JS, et al. (1999). Telomerase RNA expression during progression of gastric cancer. Hum. Pathol. 30: 1302-1308.
20. Reddel RR and Bryan TM (2003). Alternative lengthening of telomeres: dangerous road less travelled. Lancet 361: 1840-1841.
21. Smogorzewska A and de Lange T (2004). Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 73: 177-208.
22. Stewart SA (2005). Telomere maintenance and tumorigenesis: an "ALT"ernative road. Curr. Mol. Med. 5: 253-257.
23. Usselmann B, Newbold M, Morris AG and Nwokolo CU (2001). Telomerase activity and patient survival after surgery for gastric and oesophageal cancer. Eur. J. Gastroenterol. Hepatol. 13: 903-908.
24. Yokozaki H, Yasui W and Tahara E (2001). Genetic and epigenetic changes in stomach cancer. Int. Rev. Cytol. 204: 49-95.
25. Yoo J, Park SY, Kang SJ, Kim BK, et al. (2003). Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas. Mod. Pathol. 16: 700-707.